Stephens restated their overweight rating on shares of CareDx ( NASDAQ:CDNA – Get Rating ) in a research note published on Tuesday morning, Benzinga reports. The firm currently has a $19.00 target price on the stock. A number of other brokerages also recently issued reports on CDNA. Raymond James reduced their price objective on shares of CareDx from $26.00 to $24.00 and set a strong-buy rating on the stock in a research note on Tuesday, January 31st. The Goldman Sachs Group dropped their target price on shares of CareDx from $29.

https://www.dailypolitical.com/2023/03/04/stephens-reiterates-overweight-rating-for-caredx-nasdaqcdna.html

#dailypolitical